Comparison of Two Liraglutide Formulations in Healthy Subjects
Status:
Completed
Trial end date:
2006-06-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe. The aim of this trial is to test for bioequivalence of the
phase 3a formulation of liraglutide at pH 8.15 (formulation 4) and liraglutide at pH 7.7
(formulation 3).